Skip to main content
. 2021 May 21;268(12):4816–4823. doi: 10.1007/s00415-021-10600-y

Table 2.

Clinical data of first and last episodes of SE; data given as n (%) unless otherwise indicated

n First SE n Last SE for patients with > 1 SE
Bilateral tonic–clonic SE 81 63 (77.8) 44 20 (45.5)
SE as first seizure 86

16 (18.6)

6.4% of total cohort

Time from seizure onset to first SE in years (median, IQR) 87 6 (0–20)
Cause of SE 74 39
 Fever/infection 5 (6.8) 2 (5.1)
 ASM change 4 (5.4) 9 (23.1)
 Sleep deprivation 4 (5.4) 1 (2.6)
 Acute cerebral damage 4 (5.4) 0
 Substance withdrawal 2 (2.7) 1 (2.6)
 Missed ASM intake 1 (1.4) 0
 Specific other cause 3 (4.1) 0
 No identifiable cause 51 (68.9) 26 (66.7)
Seizures in the last three months before the SE 70 40 (57.1) 36 30 (83.3)
Duration of SE 76 42
 5–29 min 55 (72.4) 28 (66.7)
 30–59 min 3 (3.9) 4 (9.5)
 60 min–24 h 15 (19.7) 8 (19.0)
 > 24 h 3 (3.9) 2 (4.8)
Rescue medication administered by relatives 77 15 (19.5) 43 18 (41.9)
Rescue medication administered by medical personnel 68 40 (58.8) 39 16 (35.6)
General anaesthesia 79 6 (7.6) 44 1 (2.3)
Number of current ASM at onset of SE 71 38
 0 31 (43.7) 3 (7.9)
 1 22 (31.0) 12 (31.6)
 2 14 (19.7) 10 (26.3)
 3 3 (4.2) 8 (21.1)
 4 1 (1.4) 1 (2.6)
  > 4 0 4 (10.5)
Modification of ASM regime because of SE 71 54 (76.1) 40 26 (65.0)

SE status epilepticus; ASM anti-seizure medication; IQR, interquartile range